CannPal Animal Therapeutics Limited announced it has entered into a Memorandum of Understanding with The University of Melbourne to broaden the company's research pipeline. Under the terms of MOU, CannPal and the University will work on terms to establish a cooperative relationship in the field of veterinary science to complete a pilot study to determine the efficacy of cannabidiol (CBD) treatment for epilepsy in dogs in 2019.